BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2123573)

  • 1. [Extracorporeal methods of therapy in lymphatic tumors].
    Ryzhko VV; Andreeva NE; Gorodetskiĭ VM; Konovalova VI; Aleksanian MZh; Sinitsina TV
    Ter Arkh; 1990; 62(7):59-63. PubMed ID: 2123573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic apheresis for the renal complications of multiple myeloma and the dysglobulinemias.
    Kaplan AA
    Ther Apher; 2001 Jun; 5(3):171-5. PubMed ID: 11467752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [B lymphoproliferative syndrome with characteristics common to chronic lymphatic leukemia, Waldenström disease and plasmacytic leukemia].
    Tosato F; Fossaluzza V; Sala P; Tonutti E
    Minerva Med; 1984 Nov; 75(44):2691-4. PubMed ID: 6440066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patients.
    Nishikubo CY; Kunkel LA; Figlin R; Belldegrun A; Rosen P; Elashoff R; Wang H; Territo MC
    Cancer; 1996 Dec; 78(11):2421-6. PubMed ID: 8941014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lung involvement in lymphoid and lympho-plasmocytic proliferations (except lymphomas)].
    Uzunhan Y; Cadranel J; Boissel N; Gardin C; Arnulf B; Bergeron A
    Rev Mal Respir; 2010 Jun; 27(6):599-610. PubMed ID: 20610075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasmapheresis in the treatment of paraproteinemic hemoblastoses].
    Ryzhko VV; Gorodetskiĭ VM
    Ter Arkh; 1983; 55(11):70-5. PubMed ID: 6419367
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenström's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.
    Siami GA; Siami FS
    Ther Apher; 1999 Feb; 3(1):8-19. PubMed ID: 10079800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
    Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
    Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].
    Ponzone A; Tarocco RP; Nicola P
    Minerva Pediatr; 1970 Dec; 22(51):2542-60. PubMed ID: 4993895
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasmapheresis in patients with leukaemia, multiple myeloma and immune complex diseases.
    Mód A; Füst G; Harsányi V; Natonek K; Poros A; Szabó J; Hollán SR
    Haematologia (Budap); 1981; 14(1):49-56. PubMed ID: 6454615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of emergency apheresis in the management of plasma cell disorders.
    Kalayoglu-Besisik S
    Transfus Apher Sci; 2018 Feb; 57(1):35-39. PubMed ID: 29477943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia].
    Mokeeva RA; Zhuravlev VS
    Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical utilization of plasmapheresis and cyclophosphamide in the treatment of malignant lymphoproliferative processes.
    Sakalová A; Gazová S; Hrubisko M; Gáliková J
    Neoplasma; 1973; 20(3):335-9. PubMed ID: 4199115
    [No Abstract]   [Full Text] [Related]  

  • 14. [Waldenström's macroglobulinemia and cerebral lymphoplasmocytic proliferation: Bing and Neel syndrome. Apropos of a new case].
    Civit T; Coulbois S; Baylac F; Taillandier L; Auque J
    Neurochirurgie; 1997; 43(4):245-9. PubMed ID: 9686227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of plasmapheresis on the PF-0.5 blood separator in patients with paraproteinemic hemoblastoses].
    Abdullaev OM; Postnikov AA; Prigozhina TA; Likhovetskaia ZM; Mokeeva RA
    Ter Arkh; 1987; 59(10):77-81. PubMed ID: 2448887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome].
    Amamiya Y; Baba M; Hisamitsu J; Ito T; Amaki T
    Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemostatic abnormalities in multiple myeloma and related disorders.
    Glaspy JA
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1301-14. PubMed ID: 1452513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reestablishment of plasma proteins after plasmapheresis in patients with paraproteinemic hemoblastosis].
    Movshev BE; Kalinin NN; Petrov MM; Petrova VI
    Ter Arkh; 1999; 71(10):40-3. PubMed ID: 10612173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation.
    Reinhart WH; Lutolf O; Nydegger UR; Mahler F; Straub PW
    J Lab Clin Med; 1992 Jan; 119(1):69-76. PubMed ID: 1727909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apheresis in hematologic and oncologic disease.
    Cohen RJ
    Hosp Pract (Off Ed); 1983 Oct; 18(10):199-205. PubMed ID: 6413369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.